insights_auto
Why is BOT down 9,09%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,010 A$
arrow_downward
-9,09%(-0,0010) 1D
6 қар., 16:10:28 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,01 A$
High
0,01 A$
Low
0,01 A$
Mkt. cap
30,39 млн
Avg. vol.
9,20 млн
Volume
23,69 млн
52-wk high
0,15 A$
52-wk low
0,01 A$
EPS
-0,03 A$
Shares outstanding
2,76 млрд
No. of employees
11
Open
0,01 A$
High
0,01 A$
Low
0,01 A$
Mkt. cap
30,39 млн
Avg. vol.
9,20 млн
Volume
23,69 млн
52-wk high
0,15 A$
52-wk low
0,01 A$
EPS
-0,03 A$
Shares outstanding
2,76 млрд
No. of employees
11
News stories
From web sources and news partners
Bloomberg.com
·
6 сағат бұрын
Wall Street Strategists Call Stock Rout a Fresh Reason to Buy
Yahoo Finance
·
7 сағат бұрын
Tech stocks are now cheaper than the S&P 500 for the first time since 2017 — here's what history says comes next: Chart of the Day
Fox Business
·
22 сағат бұрын
Nasdaq rallies as chip stocks recover from brutal losses
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com